Literature DB >> 15488816

Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.

Anne L Coleman1, Mae O Gordon, Julia A Beiser, Michael A Kass.   

Abstract

PURPOSE: Higher baseline pattern standard deviation (PSD) and larger vertical cup-to-disk ratio (VC/D) were factors in the predictive model for the development of primary open-angle glaucoma (POAG) in the Ocular Hypertension Treatment Study. Because early changes in PSD and VC/D may be indicative of early POAG damage, we repeated the prediction model excluding PSD and VC/D.
DESIGN: Reanalysis of baseline factors for the development of POAG.
METHODS: We compared the hazard ratios for baseline factors predictive of POAG in the multivariate Cox proportional hazards model that included PSD and VC/D and in the model that excluded them.
RESULTS: Hazard ratios for baseline factors predictive of POAG in Ocular Hypertension Treatment Study were not substantially affected by the inclusion or exclusion of PSD and VC/D in the proportional hazards model.
CONCLUSION: Whether PSD or VC/D was included in the Cox proportional hazards model, the same baseline factors were statistically significant and their hazard ratios were essentially similar.

Entities:  

Mesh:

Year:  2004        PMID: 15488816     DOI: 10.1016/j.ajo.2004.05.030

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Association of Fellow Eye With Study Eye Disease Trajectories and Need for Fellow Eye Treatment in Collaborative Initial Glaucoma Treatment Study (CIGTS) Participants.

Authors:  Leslie M Niziol; Brenda W Gillespie; David C Musch
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389

2.  Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study.

Authors:  Donald L Budenz; Douglas R Anderson; William J Feuer; Julia A Beiser; Joyce Schiffman; Richard K Parrish; Jody R Piltz-Seymour; Mae O Gordon; Michael A Kass
Journal:  Ophthalmology       Date:  2006-09-25       Impact factor: 12.079

3.  A deep-learning system predicts glaucoma incidence and progression using retinal photographs.

Authors:  Fei Li; Yuandong Su; Fengbin Lin; Zhihuan Li; Yunhe Song; Sheng Nie; Jie Xu; Linjiang Chen; Shiyan Chen; Hao Li; Kanmin Xue; Huixin Che; Zhengui Chen; Bin Yang; Huiying Zhang; Ming Ge; Weihui Zhong; Chunman Yang; Lina Chen; Fanyin Wang; Yunqin Jia; Wanlin Li; Yuqing Wu; Yingjie Li; Yuanxu Gao; Yong Zhou; Kang Zhang; Xiulan Zhang
Journal:  J Clin Invest       Date:  2022-06-01       Impact factor: 19.456

Review 4.  Diagnostic tools for calculation of glaucoma risk.

Authors:  Steve L Mansberger; Felipe A Medeiros; Mae Gordon
Journal:  Surv Ophthalmol       Date:  2008-11       Impact factor: 6.048

Review 5.  Cyclodestructive procedures for non-refractory glaucoma.

Authors:  Manuele Michelessi; Amanda K Bicket; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2018-04-25

Review 6.  An Updated Review on the Genetics of Primary Open Angle Glaucoma.

Authors:  Khaled Abu-Amero; Altaf A Kondkar; Kakarla V Chalam
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

7.  Intra-Subject Variability and Diurnal Cycle of Ocular Perfusion Pressure as Characterized by Continuous Telemetry in Nonhuman Primates.

Authors:  Katherine I Wilson; Pooja Godara; Jessica V Jasien; Emma Zohner; Jeffrey S Morris; Christopher A Girkin; Brian C Samuels; J Crawford Downs
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

8.  Ocular Pulse Amplitude Correlates With Ocular Rigidity at Native IOP Despite the Variability in Intraocular Pulse Volume With Each Heartbeat.

Authors:  John E Markert; Daniel C Turner; Jessica V Jasien; Cyril N A Nyankerh; Brian C Samuels; J Crawford Downs
Journal:  Transl Vis Sci Technol       Date:  2022-09-01       Impact factor: 3.048

9.  Estimating the risk of developing glaucoma.

Authors:  Felipe A Medeiros; Robert N Weinreb
Journal:  Open Ophthalmol J       Date:  2009-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.